CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling

Qian Zhong,Yuxin Fang,Qiuhua Lai,Shanci Wang,Chengcheng He,Aimin Li,Side Liu,Qun Yan
DOI: https://doi.org/10.21203/rs.3.rs-19746/v1
2020-03-30
Abstract:Abstract Background: Crosstalk between cancer cells and tumor-associated macrophages (TAMs) mediates tumor progression in colorectal cancer (CRC). Cytoplasmic polyadenylation element binding protein 3 (CPEB3) has been proved to exhibit tumor suppressive role in CRC.Methods: The expression of CPEB3, CD86 and CD163 was determined in CRC tissues. SW480 or HCT116 cells with overexpressed CPEB3 and LoVo or RKO cells with knockdown CPEB3 were constructed. Stably transfected CRC cells were co-cultured with THP-1 macrophages to determine the malignant phenotype of CRC cells, the macrophage polarization and the secretory signals. The inhibition of CPEB3 on tumor progression and M2-like TAM polarization was confirmed in nude mice.Results: Decreased CPEB3 expression in CRC was associated with less CD86+ TAMs number and more CD163+ TAMs number. CPEB3 knockdown in CRC cells increased CD163+ TAMs number and the expression of IL1RA, IL-6, IL-4 and IL-10 in TAMs supernatants. TAMs enhanced CRC cells proliferation and invasion via IL-6, then activated the IL-6R/STAT3 pathway in CRC cells. However, CPEB3 reduced the IL-6R protein level by directly binding to IL-6R mRNA, leading to decreased phosphorylated-STAT3 expression in CRC cells. CCL2 was significantly increased in knockdown CPEB3 cells, while CCL2 antibody treatment rescued the effect of knockdown CPEB3 on promoting CD163+ TAMs polarization. Eventually, we confirmed that CPEB3 inhibits tumor progression and M2-like TAMs polarization in vivo. Conclusions: CPEB3 is involved in the crosstalk between CRC cells and TAMs by targeting IL-6R/STAT3 signaling.
What problem does this paper attempt to address?